MSN Group launches Fesobig to treat urinary incontinence and overactive bladder EP News Bureau Mar 16, 2023 It is first-line therapy recommended by various international treatment guideline for overactive bladder (OAB)
Lupin receives tentative US FDA approval for Mirabegron ER Tablets EP News Bureau Jun 28, 2019 Lupin’s Mirabegron ER Tablets, 25 mg and 50 mg, is a generic version of Myrbetriq Extended Release Tablets, 25 mg and 50 mg, of…
